Stage IV Melanoma Completed Phase 3 Trials for Sargramostim (DB00020)

IndicationStatusPhase
DBCOND0028660 (Stage IV Melanoma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs